BioNTech SE - ADR

NASDAQ:BNTX   4:00:00 PM EDT
104.64
-1.79 (-1.68%)
7:40:27 PM EDT: $106.12 +1.48 (+1.41%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)24.67B
Current PE3.95
Forward PE 18.79
2yr Forward PE 33.97
See more stats
Estimates Current Quarter
Revenue$1.31 Billion
Adjusted EPS$0.96
See more estimates
10-Day MA$110.64
50-Day MA$111.71
200-Day MA$124.90
See more pivots

BioNTech SE - ADR Stock, NASDAQ:BNTX

An der Goldgrube 12, Mainz, Rheinland-Pfalz 55131
Germany
Phone: +49.6131.9084.0
Number of Employees: 4530

Description

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.